OxThera AB is Being Granted US Patent for Oxalobacter Secretagogues (PR Newswire)

UF startup OxThera AB, a privately-held Stockholm-based biopharmaceutical company, announced a granted US patent on Oxalobacter formigenes secretagogues. OxThera AB, a spinout of Ixion, is a UF Innovate | Sid Martin Biotech alumnus. Oxabact®, a formulation of highly concentrated lyophilized Oxalobacter formigenes, is being developed by OxThera AB as a potential treatment for patients with […]

Entrinsic Health Solutions and Nestlé Health Science Enter Global Partnership for Novel Amino Acid Product enterade® (BusinessWire)

UF startup Entrinsic Health Solutions (EHS), an innovative health sciences company, announced that they have entered into a partnership with Nestlé Health Science (NHSc), a global innovative leader pioneering premium-quality, science-based nutritional health solutions. The partnership gives NHSc the exclusive rights to market EHS’s enterade® product. This partnership is structured as a worldwide commercial license […]

UF Innovate | The Hub Resident Client aha Pure Foods Wins Cox Business’ Get Started Gainesville Business Pitch Competition (BusinessWire)

UF Innovate | The Hub, a leading business incubator in the University of Florida business incubation system, announced that resident client aha Pure Foods, a vegan soup company, is the 2018 winner of the Cox Business’ Get Started Gainesville Business Pitch Competition. Cox Business selected five finalists out of more than 40 local business applicants […]

DNAtrix and Valo Therapeutics Enter into Strategic Partnership to Develop Peptide-Coated Oncolytic Viruses for Treating Cancer (PR Newswire)

UF startup DNAtrix and Valo Therapeutics announced an exclusive R&D collaboration to develop enhanced vaccines using DNAtrix’s clinical stage viruses and Valo’s proprietary antigenic peptide technology. DNAtrix’s clinical stage oncolytic adenovirus platform and Valo’s PeptiCRAd (Peptide-coated Conditionally Replicating Adenovirus) vaccination technology will be combined to generate a novel “armed oncolytic vaccine” for cancer therapy. While […]

OxThera Presents Encouraging 52-Week Efficacy and Safety Data for Oxabact® in Primary Hyperoxaluria Type 1 (PH1) Patients with ESRD (PR Newswire)

UF startup OxThera AB, a Stockholm-based privately-held biopharmaceutical company and leader in the field of microbiome derived biotherapeutics, announced a poster presentation showing encouraging Oxabact® efficacy and safety data from the long-term study OC5-OL-01, at the Annual Meeting of the American Society of Nephrology Kidney Week 2018 in San Diego. “We are pleased to present […]

ViewRay to Supply UK’s GenesisCare With Country’s First MRIdian Systems (DOTmed)

UF startup ViewRay Inc. is set to deliver the first of Great Britain’s MRIdian MR-guided radiotherapy systems as part of a new partnership between it and the cancer service provider, GenesisCare. Deployed within the GenesisCare network, the first two systems will offer oncologists the ability to leverage soft-tissue imaging for the visualization of tumors, personalizing […]

Sun BioPharma, Inc. to Present Results of New Pancreatitis Study at American Pancreatic Association Meeting in Miami Beach (Globe Newswire)

UF startup Sun BioPharma, Inc., a clinical stage biopharmaceutical company specializing in disruptive therapeutics for pancreatic diseases, announced that it will present results of a new study entitled “Effect of SBP-101 in a Mouse Model of Cerulein-induced Acute Pancreatitis” at the American Pancreatic Association meeting in Miami on Nov. 1. The study, performed in collaboration […]